Kevin Kotler - Net Worth and Insider Trading

Kevin Kotler Net Worth

The estimated net worth of Kevin Kotler is at least $28 Million dollars as of 2024-04-29. Kevin Kotler is the Director of BioDelivery Sciences International Inc and owns about 5,058,489 shares of BioDelivery Sciences International Inc (BDSI) stock worth over $28 Million. Details can be seen in Kevin Kotler's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kevin Kotler has not made any transactions after 2021-11-12 and currently still holds the listed stock(s).

Transaction Summary of Kevin Kotler

Kevin Kotler Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kevin Kotler owns 13 companies in total, including BioDelivery Sciences International Inc (BDSI) , Novelion Therapeutics Inc (NVLNF) , and Avadel Pharmaceuticals PLC (AVDL) among others .

Click here to see the complete history of Kevin Kotler’s form 4 insider trades.

Insider Ownership Summary of Kevin Kotler

Ticker	Comapny	Transaction Date	Type of Owner
BDSI	BioDelivery Sciences International Inc	2021-11-12	director
NVLNF	Novelion Therapeutics Inc	2020-01-09	10 percent owner
AVDL	Avadel Pharmaceuticals PLC	2016-01-01	10 percent owner
PETX	Aratana Therapeutics Inc	2019-07-18	10 percent owner
CORI	Corium International Inc	2018-11-27	10 percent owner
SCTL	Societal CDMO Inc	2014-09-05	10 percent owner
MRTX	Mirati Therapeutics Inc	2017-11-16	10 percent owner
PGNX	Progenics Pharmaceuticals Inc	2017-02-13	10 percent owner
AEGR	Aegerion Pharmaceuticals Inc	2016-11-29	10 percent owner
SSKN	Strata Skin Sciences Inc	2014-02-05	10 percent owner
DXTRQ	Dex Liquidating Co	2015-09-04	10 percent owner & other: See Explanation of Responses
TVTX	Travere Therapeutics Inc	2015-01-13	10 percent owner
HRTX	Heron Therapeutics Inc	2023-02-22	director

Kevin Kotler Latest Holdings Summary

Kevin Kotler currently owns a total of 1 stock. Kevin Kotler owns 5,058,489 shares of BioDelivery Sciences International Inc (BDSI) as of November 12, 2021, with a value of $28 Million.

Latest Holdings of Kevin Kotler

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
BDSI	BioDelivery Sciences International Inc	2021-11-12	5,058,489	5.59	28,276,954

Holding Weightings of Kevin Kotler

Kevin Kotler Form 4 Trading Tracker

According to the SEC Form 4 filings, Kevin Kotler has made a total of 3 transactions in BioDelivery Sciences International Inc (BDSI) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in BioDelivery Sciences International Inc is the acquisition of 100,000 shares on November 12, 2021, which cost Kevin Kotler around $320,000.

Insider Trading History of Kevin Kotler

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kevin Kotler Trading Performance

GuruFocus tracks the stock performance after each of Kevin Kotler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin Kotler is 10.15%. GuruFocus also compares Kevin Kotler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin Kotler within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kevin Kotler's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kevin Kotler

Average Return

No transaction record over 1 year.

Outperforming Transactions

No transaction record over 1 year.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-10.02	10.15	1.89
Relative Return to S&P 500(%)	-10.19	10.54	-11.98

Kevin Kotler Ownership Network

Ownership Network List of Kevin Kotler

No Data

Ownership Network Relation of Kevin Kotler

Kevin Kotler Owned Company Details

What does BioDelivery Sciences International Inc do?

Who are the key executives at BioDelivery Sciences International Inc?

Kevin Kotler is the director of BioDelivery Sciences International Inc. Other key executives at BioDelivery Sciences International Inc include See Remarks James Vollins , See Remarks Mary Theresa Coelho , and director & Chief Executive Officer Jeffrey Allen Bailey .

BioDelivery Sciences International Inc (BDSI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of BioDelivery Sciences International Inc (BDSI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioDelivery Sciences International Inc (BDSI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BioDelivery Sciences International Inc (BDSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

BioDelivery Sciences International Inc Insider Transactions

No Available Data

What does Novelion Therapeutics Inc do?

Who are the key executives at Novelion Therapeutics Inc?

Kevin Kotler is the 10 percent owner of Novelion Therapeutics Inc. Other key executives at Novelion Therapeutics Inc include 10 percent owner Broadfin Healthcare Master Fund Ltd , 10 percent owner Broadfin Capital, Llc , and 10 percent owner Stonepine Capital, L.p. .

Novelion Therapeutics Inc (NVLNF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Novelion Therapeutics Inc (NVLNF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Novelion Therapeutics Inc (NVLNF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Novelion Therapeutics Inc (NVLNF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Novelion Therapeutics Inc Insider Transactions

No Available Data

What does Avadel Pharmaceuticals PLC do?

Who are the key executives at Avadel Pharmaceuticals PLC?

Kevin Kotler is the 10 percent owner of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .

Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary

Over the past 18 months, Kevin Kotler made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net purchase of 9,000 shares made by Thomas S Mchugh , a net sale of 103,975 shares made by Mark Anthony Mccamish , and a net purchase of 33,000 shares made by Eric J Ende .

In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 70,500 shares were bought by its insiders, resulting in a net sale of 33,475 shares.

Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avadel Pharmaceuticals PLC Insider Transactions

No Available Data

What does Aratana Therapeutics Inc do?

Who are the key executives at Aratana Therapeutics Inc?

Kevin Kotler is the 10 percent owner of Aratana Therapeutics Inc. Other key executives at Aratana Therapeutics Inc include 10 percent owner Broadfin Healthcare Master Fund Ltd , 10 percent owner Broadfin Capital, Llc , and director & President and CEO Craig A Tooman .

Aratana Therapeutics Inc (PETX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aratana Therapeutics Inc (PETX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aratana Therapeutics Inc (PETX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aratana Therapeutics Inc (PETX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aratana Therapeutics Inc Insider Transactions

No Available Data

What does Corium International Inc do?

Who are the key executives at Corium International Inc?

Kevin Kotler is the 10 percent owner of Corium International Inc. Other key executives at Corium International Inc include 10 percent owner Broadfin Healthcare Master Fund Ltd , 10 percent owner Broadfin Capital, Llc , and Chief Business Officer Joseph J. Sarret .

Corium International Inc (CORI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Corium International Inc (CORI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Corium International Inc (CORI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Corium International Inc (CORI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Corium International Inc Insider Transactions

No Available Data

What does Societal CDMO Inc do?

Who are the key executives at Societal CDMO Inc?

Kevin Kotler is the 10 percent owner of Societal CDMO Inc. Other key executives at Societal CDMO Inc include director & Chief Executive Officer Enloe J David Jr , director & 10 percent owner Mathew Paul Arens , and 10 percent owner Awm Investment Company, Inc. .

Societal CDMO Inc (SCTL) Insider Trades Summary

Over the past 18 months, Kevin Kotler made no insider transaction in Societal CDMO Inc (SCTL). Other recent insider transactions involving Societal CDMO Inc (SCTL) include a net sale of 230,000 shares made by Awm Investment Company, Inc. , a net purchase of 125,660 shares made by Enloe J David Jr , and a net purchase of 6,250,000 shares made by Mathew Paul Arens .

In summary, during the past 3 months, insiders sold 0 shares of Societal CDMO Inc (SCTL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 370,000 shares of Societal CDMO Inc (SCTL) were sold and 6,792,882 shares were bought by its insiders, resulting in a net purchase of 6,422,882 shares.

Societal CDMO Inc (SCTL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Societal CDMO Inc Insider Transactions

No Available Data

What does Mirati Therapeutics Inc do?

Who are the key executives at Mirati Therapeutics Inc?

Kevin Kotler is the 10 percent owner of Mirati Therapeutics Inc. Other key executives at Mirati Therapeutics Inc include EVP & Chief Commercial Officer Benjamin Hickey , Sr. Vice President & Chief Scie Jamie Christensen , and Interim CFO Aaron Ondrey .

Mirati Therapeutics Inc (MRTX) Insider Trades Summary

Over the past 18 months, Kevin Kotler made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 16,852 shares made by Jamie Christensen , a net sale of 12,809 shares made by Benjamin Hickey , and a net sale of 81,996 shares made by Charles M Baum .

In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 126,645 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,402,092 shares.

Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mirati Therapeutics Inc Insider Transactions

No Available Data

What does Progenics Pharmaceuticals Inc do?

Who are the key executives at Progenics Pharmaceuticals Inc?

Kevin Kotler is the 10 percent owner of Progenics Pharmaceuticals Inc. Other key executives at Progenics Pharmaceuticals Inc include Chief Medical Officer Asha Das , 10 percent owner & other: See Explanation of Responses Balaji Venkataraman , and 10 percent owner & other: See Explanation of Responses Virinder Nohria .

Progenics Pharmaceuticals Inc (PGNX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Progenics Pharmaceuticals Inc (PGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Progenics Pharmaceuticals Inc (PGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Progenics Pharmaceuticals Inc (PGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Progenics Pharmaceuticals Inc Insider Transactions

No Available Data

What does Aegerion Pharmaceuticals Inc do?

Who are the key executives at Aegerion Pharmaceuticals Inc?

Kevin Kotler is the 10 percent owner of Aegerion Pharmaceuticals Inc. Other key executives at Aegerion Pharmaceuticals Inc include director & Chief Executive Officer Mary T Szela , other: See Remarks Gregory D Perry , and General Counsel and Secretary Benjamin Harshbarger .

Aegerion Pharmaceuticals Inc (AEGR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aegerion Pharmaceuticals Inc (AEGR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aegerion Pharmaceuticals Inc (AEGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aegerion Pharmaceuticals Inc (AEGR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aegerion Pharmaceuticals Inc Insider Transactions

No Available Data

What does Strata Skin Sciences Inc do?

Who are the key executives at Strata Skin Sciences Inc?

Kevin Kotler is the 10 percent owner of Strata Skin Sciences Inc. Other key executives at Strata Skin Sciences Inc include SVP & General Manager Carlsbad Shmuel Gov , 10 percent owner 22nw Gp, Inc. , and 10 percent owner 22nw Fund, Lp .

Strata Skin Sciences Inc (SSKN) Insider Trades Summary

Over the past 18 months, Kevin Kotler made no insider transaction in Strata Skin Sciences Inc (SSKN). Other recent insider transactions involving Strata Skin Sciences Inc (SSKN) include a net purchase of 1,853,056 shares made by 22nw Fund, Lp , a net purchase of 42,000 shares made by Robert Joseph Moccia , and a net purchase of 20,000 shares made by Shmuel Gov .

In summary, during the past 3 months, insiders sold 0 shares of Strata Skin Sciences Inc (SSKN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,000 shares of Strata Skin Sciences Inc (SSKN) were sold and 1,930,207 shares were bought by its insiders, resulting in a net purchase of 1,929,207 shares.

Strata Skin Sciences Inc (SSKN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Strata Skin Sciences Inc Insider Transactions

No Available Data

What does Dex Liquidating Co do?

Who are the key executives at Dex Liquidating Co?

Kevin Kotler is the 10 percent owner & other: See Explanation of Responses of Dex Liquidating Co. Other key executives at Dex Liquidating Co include other: Former Director Younger William H Jr , V.P. & Finance & CFO & Secretary Newell Robert Y Iv , and VP,Worldwide Sales & Marketing Liam Burns .

Dex Liquidating Co (DXTRQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dex Liquidating Co (DXTRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dex Liquidating Co (DXTRQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dex Liquidating Co (DXTRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dex Liquidating Co Insider Transactions

No Available Data

What does Travere Therapeutics Inc do?

Who are the key executives at Travere Therapeutics Inc?

Kevin Kotler is the 10 percent owner of Travere Therapeutics Inc. Other key executives at Travere Therapeutics Inc include Chief Financial Officer Christopher R. Cline , director & Chief Executive Officer Eric M Dube , and VP & Corp Controller and CAO Sandra Calvin .

Travere Therapeutics Inc (TVTX) Insider Trades Summary

Over the past 18 months, Kevin Kotler made no insider transaction in Travere Therapeutics Inc (TVTX). Other recent insider transactions involving Travere Therapeutics Inc (TVTX) include a net sale of 4,306 shares made by Christopher R. Cline , a net sale of 32,591 shares made by Eric M Dube , and a net sale of 9,354 shares made by William E. Rote .

In summary, during the past 3 months, insiders sold 54 shares of Travere Therapeutics Inc (TVTX) in total and bought 0 shares, with a net sale of 54 shares. During the past 18 months, 73,182 shares of Travere Therapeutics Inc (TVTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 73,182 shares.

Travere Therapeutics Inc (TVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Travere Therapeutics Inc Insider Transactions

No Available Data

What does Heron Therapeutics Inc do?

Who are the key executives at Heron Therapeutics Inc?

Kevin Kotler is the director of Heron Therapeutics Inc. Other key executives at Heron Therapeutics Inc include EVP & Chief Development Officer William P Forbes , other: See Footnote 2 Adam Morgan , and EVP & Chief Financial Officer Ira Duarte .

Heron Therapeutics Inc (HRTX) Insider Trades Summary

Over the past 18 months, Kevin Kotler made no insider transaction in Heron Therapeutics Inc (HRTX). Other recent insider transactions involving Heron Therapeutics Inc (HRTX) include a net purchase of 2,486,744 shares made by Adam Morgan , and a net purchase of 50,000 shares made by William P Forbes .

In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc (HRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heron Therapeutics Inc (HRTX) were sold and 2,536,744 shares were bought by its insiders, resulting in a net purchase of 2,536,744 shares.

Heron Therapeutics Inc (HRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Heron Therapeutics Inc Insider Transactions

No Available Data

Kevin Kotler Mailing Address

Above is the net worth, insider trading, and ownership report for Kevin Kotler. You might contact Kevin Kotler via mailing address: C/o Broadfin Capital, Llc, 300 Park Avenue, 25th Floor, New York Ny 10022.

Discussions on Kevin Kotler

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.